PROPPER Prospective Registry of Outcomes With Penile Prosthesis
PROPPER
Prospective Registry of Outcomes With Penile Prosthesis for Erectile Restoration (PROPPER)
1 other identifier
observational
1,457
2 countries
11
Brief Summary
The purpose of this observational registry is to collect and better understand "real-world" outcomes for men undergoing penile implant surgery to treat erectile dysfunction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2011
Longer than P75 for all trials
11 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 13, 2011
CompletedFirst Submitted
Initial submission to the registry
June 24, 2011
CompletedFirst Posted
Study publicly available on registry
June 28, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2018
CompletedResults Posted
Study results publicly available
February 18, 2020
CompletedFebruary 12, 2021
January 1, 2021
6.5 years
June 24, 2011
December 16, 2019
January 25, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Number of Participants With Penile Prosthesis Overall Subject Satisfaction
Penile prosthesis overall subject satisfaction (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post-implantation
Number of Participants With Penile Prosthesis That Are Using the Device
Number of subjects using penile prosthesis at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Number of Participants With Penile Prosthesis That Are Using the Device Indicating How Often Their Use is.
Penile prosthesis use at year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Number of Times Per Month Participants With Penile Prosthesis Are Using the Device.
Penile prosthesis use at 1 year measured in number of times per month (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Number of Participants With Penile Prosthesis That Were Not Using the Device, Reasons for Non-use
Penile prosthesis reasons for non-use at 1 year (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Number of Participants With Penile Prosthesis Using the Device But Not as Often as Desired
Number of penile prosthesis subjects using the device but indicated that they were not using as often as desired (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Number of Participants With Penile Prosthesis That Are Using the Device Less Than Desired or Dissatisfied - Reason Device Used Less Than Desired or Dissatisfied
Reason why subject is using penile prosthesis less than desired or dissatisfied (effectiveness objective 1) measured using a non-validated, standard question, evaluated overall and by penile prosthesis.
1 year, post implantation
Other Outcomes (4)
Subject Reported 5-question International Index of Erectile Function (IIEF-5) Total Score, Baseline Through Five Years
Baseline through 5 years
Erection Hardness Scale Over Five Years
Baseline through 5 years
American Urology Association - Symptom Index Over Five Years
Baseline through 5 years
- +1 more other outcomes
Study Arms (1)
AMS penile prosthesis receipients
Men for whom an AMS penile prosthesis is recommended
Interventions
Non-interventional device registry. Outcomes for patients receiving marketed AMS penile prosthesis devices.
Eligibility Criteria
Men with ED in the United States and Canada.
You may qualify if:
- Willing and able to provide written informed consent prior to enrollment (if applicable).
- Willing to be seen or contacted by phone by the investigator and answer at least 2 questions related to satisfaction and device use 1 year following implantation of an AMS penile prosthesis.
You may not qualify if:
- \- Men who are deemed by their physician to be not suitable for a penile implant will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (11)
Urology Centers of Alabama
Homewood, Alabama, 35209, United States
El Camino Urology Medical Group
Mountain View, California, 94040, United States
Kaiser Permanente
San Diego, California, 92154, United States
SIU School of Medicine
Springfield, Illinois, 62794-9664, United States
Ark-LA-Tek
Bossier City, Louisiana, 71111, United States
Lahey Clinic
Burlington, Massachusetts, 01805, United States
The Urology Team
Austin, Texas, 78715, United States
Baylor College of Medicine
Houston, Texas, 77030, United States
Urology San Antonio Research, PA
San Antonio, Texas, 78229, United States
University of Utah
Salt Lake City, Utah, 84132, United States
University of Ottawa
Ottawa, Ontario, K1H 8L6, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Amanda Vail, Clinical Project Manager
- Organization
- Boston Scientific
Study Officials
- PRINCIPAL INVESTIGATOR
Gerard Henry, MD
Ark-LA-Tek
- PRINCIPAL INVESTIGATOR
Anthony J. Bella, MD
University of Ottawa
- PRINCIPAL INVESTIGATOR
Edward Karpman, MD
El Camino Urology Medical Group
- PRINCIPAL INVESTIGATOR
LeRoy Jones, MD
Urology San Antonio Research PA
- PRINCIPAL INVESTIGATOR
Bryan T Kansas, MD
The Urology Team
- PRINCIPAL INVESTIGATOR
Brian Christine, MD
Urology Centers of Alabama
- PRINCIPAL INVESTIGATOR
Kevin McVary, MD
SIU School of Medicine
- PRINCIPAL INVESTIGATOR
James Hotaling, MD
University of Utah
- PRINCIPAL INVESTIGATOR
Mohit Khera, MD
Baylor College of Medicine
- PRINCIPAL INVESTIGATOR
Eugene Rhee, MD
Kaiser Permanente
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 24, 2011
First Posted
June 28, 2011
Study Start
June 13, 2011
Primary Completion
November 30, 2017
Study Completion
July 25, 2018
Last Updated
February 12, 2021
Results First Posted
February 18, 2020
Record last verified: 2021-01